35th Cycle Research Lines


  1. Decellularized colorectal cancer matrix as bioactive microenvironment for in vitro 3D cancer research (Project manager: Dr. Marco Agostini - DiSCOG)
  2. Research of new faecal biomarkers for the non-invasive diagnosis of colorectal and pancreatic carcinoma using mass spectrometry techniques (Project manager: Prof. Daniela Basso - DiMed)
  3. New markers of diagnosis, prognosis and response to the therapy of onco-hematological diseases, identified through high-throughput molecular approaches (Project manager: Dr. Monica Facco - DiMed)
  4. Mechanisms of cell proliferation in lymphoproliferative diseases (Project manager: Prof. GIanpietro Semenzato - DiMed)
  5. Pathobiology of multiple myeloma and aggressive non-Hodgkin B lymphomas (Project manager: Prof. Francesco Piazza - DiMed)
  6. Harnessing redox homeostasis and cell death pathways for targeting lymphoid neoplasms (Project manager: Prof. Vincenzo Ciminale - DiSCOG)
  7. Studies on extra-telomeric functions of TERT: implications for new therapeutic approaches against cancer (Project manager: Prof. Anita De Rossi - DiSCOG)
  8. The role of BCAT1 and BCAAs metabolism in NOTCH1-induced T-cell lymphoblastic leukemia (Project manager: Dr. Valeria Tosello, Istituto Oncologico Veneto)
  9. Oligometastase: a multidisciplinary approach (Project manager: Prof. Pietro Ruggieri - DiSCOG)
  10. An integrative approach of imaging the immune suppressive landscape in glioma patients (Project manager: Prof. Susanna Mandruzzato - DiSCOG)
  11. Identification of the genetic alterations useful to predict the response to targeted therapy in BRAF-mutated metastatic melanoma patients (Project managers: Dr. Chiara Menin, Dr. Arcangela De Nicolo - Istituto Oncologico Veneto)
  12. Clinical, biohumoral, anatomopathological and molecular predictive factors of response and toxicity to immunotherapy in solid tumors (Project manager: Prof. Pierfranco Conte - DiSCOG)
  13. The role of Polycomb in DNA damage and metabolism (Project manager: Dr. Giovanni Tonon - Ospedale San Raffaele Milano)
  14. Genetic and metabolic evolution of experimental tumors treated with anti-angiogenic drugs (Project manager: Dr. Stefano Indraccolo - DiSCOG)